drugset / Trial / NCT00812058
A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to test a new drug, RG2417, to see how the drug affects symptoms of bipolar I depression and to make sure it is safe in humans.
Timeline
- Start
- 2008-11
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Uridine | Small molecule | 2 g | Oral |